NASDAQ: MREOMereo Biopharma Group PLC Stock Ownership - Who owns Mereo Biopharma Group?
Insider buying vs selling
Have Mereo Biopharma Group PLC insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when MREO insiders and whales buy or sell their stock.
MREO Shareholders
What type of owners hold Mereo Biopharma Group PLC stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Rubric Capital Management LP | 4.00% | 31,950,000 | $8.31M | Insider |
| Rubric Capital Management LP | 1.92% | 15,307,347 | $3.98M | Institution |
| 683 Capital Management LLC | 1.88% | 15,025,000 | $3.91M | Institution |
| Ecor1 Capital LLC | 0.98% | 7,856,466 | $2.04M | Institution |
| Schonfeld Strategic Advisors LLC | 0.76% | 6,090,381 | $1.58M | Institution |
| Tejara Capital Ltd | 0.27% | 2,159,681 | $561.52k | Institution |
| Logos Global Management LP | 0.23% | 1,850,000 | $481.00k | Institution |
| Ubs Am A Distinct Business Unit Of Ubs Asset Management Americas LLC | 0.22% | 1,763,666 | $458.55k | Institution |
| Monaco Asset Management Sam | 0.20% | 1,585,214 | $412.16k | Institution |
| Ubs Group Ag | 0.20% | 1,558,931 | $405.32k | Institution |
MREO vs Biotech Stocks
Mereo Biopharma Group Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.